Muhlenkamp & Co’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-484,765	Closed	-$11.4M	–	66
2013 Q3	$11.4M	Buy	484,765 +2,865	+0.6%	+$67.3K	2.26%	21
2013 Q2	$12.9M	Buy	+481,900	New	+$12.9M	2.7%	16